BUZZ-Kymera Therapeutics falls after launching $250 mln stock offering

Reuters
06-26
BUZZ-Kymera <a href="https://laohu8.com/S/LENZ">Therapeutics</a> falls after launching $250 mln stock offering

** Kymera Therapeutics' KYMR.O shares off 5.2% at $44.04 after hours as co looks to raise equity

** Watertown, Massachusetts-based firm commences $250 mln stock offering

** It intends to use net proceeds to advance its pipeline of degrader medicines for immunological diseases

** Morgan Stanley, J.P. Morgan, Jefferies, TD Cowen and Leerink joint book-running managers for the offering

** Earlier Weds, Gilead Sciences GILD.O inked up to $750 mln cancer drug deal with Kymera

** Separately, Kymera said Sanofi SASY.PA to advance its KT-485 drug candidate into clinical testing, and co is eligible for up to $975 mln in collaboration milestone payments

** KYMR shares finished regular session on Weds down 1.4% at $46.47

** Co has 65.1 mln shares outstanding for $3 bln market cap

** Through Weds close, shares up 70% this quarter, putting them up 15.5% YTD

(Lance Tupper is a Reuters market analyst. The views expressed are his own)

((lance.tupper@tr.com 1-646-279-6380))

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10